Company intelligence / Profile preview

Tumor Zentrum Aargau

Aarau, Aargau, Switzerlandsakk.ch ↗

Ownership: Private
Development stage: Other

Overview

Tumor Zentrum Aargau is an independent private competence center for oncology, hematology, and palliative care in Switzerland. It provides comprehensive cancer patient management from diagnosis through treatment to follow-up and rehabilitation. The center collaborates closely with Hirslanden Klinik Aarau and participates in national/international research networks. Patients have access to innovative therapies via participation in ongoing clinical trials across multiple cancer indications.

Modalities: Small moleculeMonoclonal antibodyCell therapy
Industry: Academic Hospital/University/Research

Partnerships

Hirslanden Klinik AarauSwiss Association for Clinical Cancer Research (SAKK)Swiss Tumor InstituteEuropean Society for Medical Oncology (ESMO)American Society of Clinical Oncology (ASCO)DGHOESHASH

Beyond the preview

Go deeper on Tumor Zentrum Aargau.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor Zentrum Aargau.

Explore the full profile